• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 与相关病毒的生物学特性:流行病学、体征、症状、诊断和治疗。

Biology of COVID-19 and related viruses: Epidemiology, signs, symptoms, diagnosis, and treatment.

机构信息

LSU Health Shreveport, 1501 Kings Highway, Shreveport LA 71103, USA.

Department of Anesthesiology, LSU Health Shreveport, 1501 Kings Highway, Shreveport LA 71103, USA.

出版信息

Best Pract Res Clin Anaesthesiol. 2021 Oct;35(3):269-292. doi: 10.1016/j.bpa.2020.12.003. Epub 2020 Dec 8.

DOI:10.1016/j.bpa.2020.12.003
PMID:34511219
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7723419/
Abstract

Coronaviruses belong to the family Coronaviridae order Nidovirales and are known causes of respiratory and intestinal disease in various mammalian and avian species. Species of coronaviruses known to infect humans are referred to as human coronaviruses (HCoVs). While traditionally, HCoVs have been a significant cause of the common cold, more recently, emergent viruses, including severe acute respiratory syndrome coronavirus (SARS-CoV-2) has caused a global pandemic. Here, we discuss coronavirus disease (COVID-19) biology, pathology, epidemiology, signs and symptoms, diagnosis, treatment, and recent clinical trials involving promising treatments.

摘要

冠状病毒属于冠状病毒科、套式病毒目,已知可引起多种哺乳动物和禽类的呼吸道和肠道疾病。已知感染人类的冠状病毒被称为人类冠状病毒(HCoV)。虽然传统上 HCoV 是普通感冒的重要病因,但最近出现的新型冠状病毒,包括严重急性呼吸综合征冠状病毒(SARS-CoV-2),已导致全球大流行。在此,我们讨论了冠状病毒病(COVID-19)的生物学、病理学、流行病学、体征和症状、诊断、治疗以及涉及有前途治疗方法的最新临床试验。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e019/7723419/ab3048620c93/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e019/7723419/c0df7489f32f/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e019/7723419/ab3048620c93/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e019/7723419/c0df7489f32f/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e019/7723419/ab3048620c93/gr2_lrg.jpg

相似文献

1
Biology of COVID-19 and related viruses: Epidemiology, signs, symptoms, diagnosis, and treatment.COVID-19 与相关病毒的生物学特性:流行病学、体征、症状、诊断和治疗。
Best Pract Res Clin Anaesthesiol. 2021 Oct;35(3):269-292. doi: 10.1016/j.bpa.2020.12.003. Epub 2020 Dec 8.
2
Remdesivir use in the coronavirus disease 2019 pandemic: A mini-review.瑞德西韦在 2019 冠状病毒病大流行中的应用:小型综述。
J Microbiol Immunol Infect. 2021 Feb;54(1):27-36. doi: 10.1016/j.jmii.2020.09.002. Epub 2020 Oct 5.
3
A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2.《COVID-19 指南:由新型冠状病毒 SARS-CoV-2 引起的全球大流行》。
FEBS J. 2020 Sep;287(17):3633-3650. doi: 10.1111/febs.15375. Epub 2020 Jun 16.
4
Systematic review and meta-analysis of effectiveness of treatment options against SARS-CoV-2 infection.针对 SARS-CoV-2 感染的治疗方案有效性的系统评价和荟萃分析。
J Med Virol. 2021 Feb;93(2):775-785. doi: 10.1002/jmv.26302. Epub 2020 Jul 22.
5
Remdesivir: Review of Pharmacology, Pre-clinical Data, and Emerging Clinical Experience for COVID-19.瑞德西韦:针对 COVID-19 的药理学、临床前数据和新兴临床经验综述。
Pharmacotherapy. 2020 Jul;40(7):659-671. doi: 10.1002/phar.2429. Epub 2020 Jun 28.
6
Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019.新型冠状病毒病治疗药物的研究进展。
Pharmacotherapy. 2020 May;40(5):416-437. doi: 10.1002/phar.2398. Epub 2020 May 6.
7
Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.从过敏学家的角度看 COVID-19 的分子机制和流行病学。
J Allergy Clin Immunol. 2020 Aug;146(2):285-299. doi: 10.1016/j.jaci.2020.05.033. Epub 2020 Jul 2.
8
Current perspective on diagnosis, epidemiological assessment, prevention strategies, and potential therapeutic interventions for severe acute respiratory infections caused by 2019 novel coronavirus (SARS-CoV-2).关于 2019 年新型冠状病毒(SARS-CoV-2)引起的严重急性呼吸道感染的诊断、流行病学评估、预防策略和潜在治疗干预的当前观点。
Hum Vaccin Immunother. 2020 Dec 1;16(12):3001-3010. doi: 10.1080/21645515.2020.1794684. Epub 2020 Sep 3.
9
Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial.评估静脉用瑞德西韦治疗成人重症 COVID-19 的疗效和安全性:一项 3 期随机、双盲、安慰剂对照、多中心试验的研究方案。
Trials. 2020 May 24;21(1):422. doi: 10.1186/s13063-020-04352-9.
10
Preferential use of dexamethasone for fetal lung maturation in severe coronavirus disease 2019.在重症2019冠状病毒病中优先使用地塞米松促进胎儿肺成熟。
Am J Obstet Gynecol MFM. 2020 Nov;2(4):100218. doi: 10.1016/j.ajogmf.2020.100218. Epub 2020 Aug 20.

引用本文的文献

1
Coronavirus Anatomy and Its Analytical Approaches for Targeting COVID-19.冠状病毒结构及其针对 COVID-19 的分析方法。
Adv Exp Med Biol. 2024;1457:33-44. doi: 10.1007/978-3-031-61939-7_2.
2
The influence of acute lifestyle changes on NAFLD evolution in a multicentre cohort: a matter of body composition.多中心队列研究中急性生活方式改变对非酒精性脂肪性肝病演变的影响:与身体成分有关。
Nutr Diabetes. 2024 May 27;14(1):33. doi: 10.1038/s41387-024-00294-2.
3
The Impact of the COVID-19 Pandemic on Surgical Services in Brazil's Healthcare System: A Retrospective Cross-Sectional Study.

本文引用的文献

1
The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020.2019新型冠状病毒病(COVID-19)疫情的流行病学特征 - 中国,2020年
China CDC Wkly. 2020 Feb 21;2(8):113-122.
2
A Case Report of COVID-19 in New Orleans, Louisiana: Highlighting the Complexities of Prognostication in a Critically Ill Patient.路易斯安那州新奥尔良市一例新冠肺炎病例报告:凸显危重症患者预后评估的复杂性
Palliat Med Rep. 2020 Oct 6;1(1):227-231. doi: 10.1089/pmr.2020.0087. eCollection 2020.
3
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months.
2019年冠状病毒病大流行对巴西医疗系统外科服务的影响:一项回顾性横断面研究
Cureus. 2023 Sep 4;15(9):e44693. doi: 10.7759/cureus.44693. eCollection 2023 Sep.
4
Social capital and the COVID-19 pandemic threat: The Russian experience.社会资本与新冠疫情威胁:俄罗斯的经验
Front Sociol. 2022 Dec 14;7:957215. doi: 10.3389/fsoc.2022.957215. eCollection 2022.
5
Evaluation of a novel SARS-CoV-2 rapid antigenic test diagnostic value in respiratory samples; is the reported test accuracy similar to values in the real-world? A cross-sectional study.新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)快速抗原检测在呼吸道样本中的诊断价值评估;报告的检测准确性与现实世界中的值相似吗?一项横断面研究。
Health Sci Rep. 2022 Aug 10;5(5):e765. doi: 10.1002/hsr2.765. eCollection 2022 Sep.
6
Predictors of COVID-19 Hospital Treatment Outcome.新冠病毒病住院治疗结果的预测因素
Int J Gen Med. 2021 Dec 22;14:10247-10256. doi: 10.2147/IJGM.S334544. eCollection 2021.
7
Maxillary Mucormycosis Osteomyelitis in Post COVID-19 Patients: A Series of Fourteen Cases.新冠后患者的上颌毛霉菌病性骨髓炎:14例病例系列
Diagnostics (Basel). 2021 Nov 5;11(11):2050. doi: 10.3390/diagnostics11112050.
8
COVID-19 vaccines and nanomedicine.COVID-19 疫苗与纳米医学。
Int J Dermatol. 2021 Sep;60(9):1047-1052. doi: 10.1111/ijd.15673. Epub 2021 Jun 5.
针对 SARS-CoV-2 感染的强大中和抗体可长期存在。
Science. 2020 Dec 4;370(6521):1227-1230. doi: 10.1126/science.abd7728. Epub 2020 Oct 28.
4
Emerging Neurology of COVID-19.新型冠状病毒肺炎的新兴神经学
Neurohospitalist. 2020 Oct;10(4):281-286. doi: 10.1177/1941874420936096. Epub 2020 Jul 10.
5
Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory-Confirmed COVID-19 - COVID-NET, 13 States, March 1-August 22, 2020.感染新型冠状病毒肺炎的住院孕妇的特征及母婴结局 - COVID-NET,13 个州,2020 年 3 月 1 日至 8 月 22 日。
MMWR Morb Mortal Wkly Rep. 2020 Sep 25;69(38):1347-1354. doi: 10.15585/mmwr.mm6938e1.
6
Cellular senescence as a potential mediator of COVID-19 severity in the elderly.细胞衰老作为老年人 COVID-19 严重程度的潜在介导者。
Aging Cell. 2020 Oct;19(10):e13237. doi: 10.1111/acel.13237. Epub 2020 Sep 21.
7
SARS-CoV-2 Infection: A Role for S1P/S1P Receptor Signaling in the Nervous System?SARS-CoV-2 感染:S1P/S1P 受体信号在神经系统中的作用?
Int J Mol Sci. 2020 Sep 15;21(18):6773. doi: 10.3390/ijms21186773.
8
Reduced Monocytic Human Leukocyte Antigen-DR Expression Indicates Immunosuppression in Critically Ill COVID-19 Patients.危重症 COVID-19 患者单核细胞 HLA-DR 表达降低提示免疫抑制。
Anesth Analg. 2020 Oct;131(4):993-999. doi: 10.1213/ANE.0000000000005044.
9
Estimation of incubation period distribution of COVID-19 using disease onset forward time: A novel cross-sectional and forward follow-up study.利用发病前时间估计 COVID-19 的潜伏期分布:一项新颖的横断面和前瞻性随访研究。
Sci Adv. 2020 Aug 14;6(33):eabc1202. doi: 10.1126/sciadv.abc1202. eCollection 2020 Aug.
10
COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2.COVID-19 大流行:对 SARS-CoV-2 结构、功能和 hACE2 受体识别的深入了解。
PLoS Pathog. 2020 Aug 21;16(8):e1008762. doi: 10.1371/journal.ppat.1008762. eCollection 2020 Aug.